Pathologic Spectrum of Kidney Diseases Within Very Elderly Patients who Underwent Kidney Biopsy.
作者信息
Caza Tiffany N, Kurien Anila Abraham, Larsen Luke C, Walker Patrick D
机构信息
Arkana Laboratories, Little Rock Arkansa, USA.
Renopath Center for Renal and Urological Pathology, Chennai, India.
出版信息
Kidney Int Rep. 2024 Jan 18;9(4):1132-1135. doi: 10.1016/j.ekir.2024.01.025. eCollection 2024 Apr.
Abstract
摘要
相似文献
1
Pathologic Spectrum of Kidney Diseases Within Very Elderly Patients who Underwent Kidney Biopsy.
Kidney Int Rep. 2024 Jan 18;9(4):1132-1135. doi: 10.1016/j.ekir.2024.01.025. eCollection 2024 Apr.
2
Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors.
J Int Med Res. 2016 Oct;44(5):1092-1102. doi: 10.1177/0300060516660247. Epub 2016 Sep 27.
3
Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland.
BMC Nephrol. 2016 Nov 25;17(1):194. doi: 10.1186/s12882-016-0410-8.
4
Pattern of biopsy-proven kidney disease in the elderly in a tertiary care hospital in India: a clinicopathological study.
Int Urol Nephrol. 2016 Apr;48(4):553-60. doi: 10.1007/s11255-015-1193-8. Epub 2016 Jan 12.
5
The spectrum of biopsy-proven kidney diseases in elderly Chinese patients.
Nephrol Dial Transplant. 2014 Dec;29(12):2251-9. doi: 10.1093/ndt/gfu239. Epub 2014 Jul 17.
6
Spectrum of biopsy-based renal disease in an elderly Turkish population.
Clin Nephrol. 2022 Jan;97(1):46-52. doi: 10.5414/CN110564.
7
Gerontolizing Nephrology: Spectrum of Histopathological Findings of Kidney Biopsy in the Elderly.
Indian J Nephrol. 2020 Jul-Aug;30(4):264-269. doi: 10.4103/ijn.IJN_275_19. Epub 2020 Feb 26.
8
Safety of kidney biopsy in elderly: a prospective study.
Int Urol Nephrol. 2006;38(3-4):815-20. doi: 10.1007/s11255-006-0088-0. Epub 2006 Dec 2.
9
Importance of renal biopsy in patients aged 60 years and older: Experience from a tertiary care hospital.
Saudi J Kidney Dis Transpl. 2018 Jan-Feb;29(1):140-144. doi: 10.4103/1319-2442.225195.
10
Changes in spectrum of biopsy-proven kidney diseases within decade: an analysis based on 10 199 cases from South China.
Postgrad Med J. 2023 Dec 21;100(1179):20-27. doi: 10.1093/postmj/qgad094.
本文引用的文献
1
Increasing Incidence of Inadequate Kidney Biopsy Samples Over Time: A 16-Year Retrospective Analysis From a Large National Renal Biopsy Laboratory.
Kidney Int Rep. 2021 Dec 8;7(2):251-258. doi: 10.1016/j.ekir.2021.11.026. eCollection 2022 Feb.
2
Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly.
Sci Rep. 2021 Dec 29;11(1):24479. doi: 10.1038/s41598-021-04274-9.
3
Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada.
JAMA Netw Open. 2020 Sep 1;3(9):e2017150. doi: 10.1001/jamanetworkopen.2020.17150.
4
Evaluation of kidney biopsies in elderly patients.
Int Urol Nephrol. 2019 May;51(5):869-874. doi: 10.1007/s11255-019-02109-1. Epub 2019 Mar 4.
5
Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Hum Pathol. 2011 May;42(5):649-58. doi: 10.1016/j.humpath.2010.08.020. Epub 2011 Feb 2.
6
Timing of complications in percutaneous renal biopsy.
J Am Soc Nephrol. 2004 Jan;15(1):142-7. doi: 10.1097/01.asn.0000102472.37947.14.
7
Incidence of biopsy-proven primary glomerulonephritis in an Italian province.
Am J Kidney Dis. 1996 May;27(5):631-9. doi: 10.1016/s0272-6386(96)90096-7.
8
Complications of percutaneous renal biopsy: a review of 37 years' experience.
Clin Nephrol. 1992 Sep;38(3):135-41.
9
Complications of percutaneous renal biopsy: an analysis of 1,000 consecutive biopsies.
Clin Nephrol. 1975 Dec;4(6):223-7.
Zotero 插件